Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Vignuzzi

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Science (New York, N.Y.)|July 30, 2021
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2Tia A Tummino, Veronica V Rezelj, Benoit Fischer, et al.
Nature Cell Biology|January 14, 2022
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformationMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Science (New York, N.Y.)|November 6, 2020
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive SpikeMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Nature Communications|September 27, 2023
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targetsKelsey M Haas, Michael J McGregor, Mehdi Bouhaddou, et al.
Cell|July 10, 2020
The Global Phosphorylation Landscape of SARS-CoV-2 InfectionMehdi Bouhaddou, Danish Memon, Bjoern Meyer, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-RepurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Nature|May 1, 2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Mbio|January 26, 2023
Virology under the Microscope-a Call for Rational DiscourseFelicia Goodrum, Anice C Lowen, Seema Lakdawala, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Science (New York, N.Y.)|July 30, 2021
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2Tia A Tummino, Veronica V Rezelj, Benoit Fischer, et al.
Nature Cell Biology|January 14, 2022
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformationMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Science (New York, N.Y.)|November 6, 2020
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive SpikeMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Nature Communications|September 27, 2023
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targetsKelsey M Haas, Michael J McGregor, Mehdi Bouhaddou, et al.
Cell|July 10, 2020
The Global Phosphorylation Landscape of SARS-CoV-2 InfectionMehdi Bouhaddou, Danish Memon, Bjoern Meyer, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-RepurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Nature|May 1, 2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Mbio|January 26, 2023
Virology under the Microscope-a Call for Rational DiscourseFelicia Goodrum, Anice C Lowen, Seema Lakdawala, et al.
Pageof 13